Bowen Acquisition Corp UnitBOWNU
BOWNU
About: Bowen Acquisition Corp is a blank check company.
0
Funds holding %
of 7,312 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
0% more ownership
Funds ownership: 0.09% [Q4 2024] → 0.1% (+0%) [Q1 2025]
38% less capital invested
Capital invested by funds: $95.6K [Q4 2024] → $59.3K (-$36.3K) [Q1 2025]
50% less funds holding
Funds holding: 2 [Q4 2024] → 1 (-1) [Q1 2025]
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Research analyst outlook
We haven’t received any recent analyst ratings for BOWNU.
Financial journalist opinion
Neutral
GlobeNewsWire
1 month ago
Bowen Acquisition Corp Receives NASDAQ Notification of Non-Compliance with Listing Rules
New York, NY, May 29, 2025 (GLOBE NEWSWIRE) -- Bowen Acquisition Corp (NASDAQ: BOWN) (“BOWN”), a special purpose acquisition company, announced that on May 28, 2025, it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“NASDAQ”) advising the Company that the Company does not comply with NASDAQ's Listing Rule 5250(c)(1) for continued listing because NASDAQ has not received the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2025 (the “Form 10-Q”). NASDAQ has informed the Company that it has until July 28, 2025 to submit a plan to regain compliance with respect to this delinquent report. If NASDAQ approves the Company's plan, it has the discretion to grant the Company an extension of up to 180 calendar days from the due date of the Form 10-Q (or until November 17, 2025) to regain compliance.
Neutral
GlobeNewsWire
1 year ago
Bowen Acquisition Corp Announces Entering into Merger Agreement with Shenzhen Qianzhi BioTech Company
New York, NY, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Bowen Acquisition Corp (NASDAQ: BOWN) (“BOWN”), a special purpose acquisition company, announced the execution of an agreement and plan of merger (the “Merger Agreement”) with Shenzhen Qianzhi BioTechnology Co., Ltd (“Qianzhi BioTech”), a biotech company engaged in development, manufacturing and sales of ozonated health and wellness products in China.
Charts implemented using Lightweight Charts™